玻璃体内递送miR-146抑制糖尿病大鼠模型中糖尿病诱导的视网膜功能缺陷
研究在链脲佐菌素诱导的糖尿病大鼠模型中玻璃体内注射表达rno-miR-146a的慢病毒,三个月后检测视网膜微血管渗漏和视网膜电图。结果显示miR-146过表达下调CARD10、IRAK1、TRAF6,抑制NF-κB下游基因ICAM1上调,并抑制糖尿病诱导的微血管渗漏和视网膜功能缺陷。
要点
- 玻璃体内注射lenti-miR-146a使视网膜miR-146a表达升高,下游靶基因CARD10、IRAK1、TRAF6下调。
- miR-146递送抑制糖尿病诱导的NF-κB下游基因ICAM1上调。
- miR-146递送抑制糖尿病诱导的视网膜微血管渗漏和视网膜功能缺陷。
核心结论
- 玻璃体内递送miR-146在糖尿病大鼠模型中抑制糖尿病诱导的NF-κB激活以及视网膜微血管和神经元功能缺陷。
研究设计与样本
- 研究为在体动物实验,使用年轻雄性Sprague-Dawley大鼠,单次注射链脲佐菌素(65 mg/kg)诱导糖尿病。
- 糖尿病1周后玻璃体内注射慢病毒(4 μl,约10^6 CFU/mL),糖尿病3个月后行Evans blue渗漏检测和视网膜电图。
- 体外实验使用人视网膜内皮细胞(HRECs)验证lenti-miR-146a转导及miR-146a表达升高。
主要发现
- lenti-miR-146a在体外稳健转导HRECs并升高miR-146a表达。
- 在体玻璃体内注射lenti-miR-146a使视网膜miR-146a表达升高,关键下游靶基因CARD10、IRAK1和TRAF6下调。
- 玻璃体内递送miR-146抑制糖尿病诱导的NF-κB下游基因ICAM1上调、微血管渗漏和视网膜功能缺陷。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Previously, we showed that microRNA-146 (miR-146) is a pivotal negative feedback regulator of multiple nuclear factor kappa-B (NF-κB) activation pathways in retinal endothelial cells (RECs). We hypothesized that miR-146 plays an important role in diabetic retinopathy (DR) by inhibiting diabetes-induced inflammatory response in the retina. The purpose of the current study is to test this hypothesis in vivo. METHODS: Lentiviruses expressing rno-miR-146a, lenti-miR-146a, and negative control oligonucleotide with scrambled sequence, lenti-miR-neg ctl, were produced. Young male Sprague-Dawley rats were injected with a single dose of streptozotocin ([STZ] 65 mg/kg) to induce diabetes. One week after diabetes, animals were injected with lentivirus intravitreally (4 μl, ∼106 CFU/mL). Three months after diabetes, retinal microvascular leakage was tested by Evans blue assay; retinal function by electroretinogram (ERG). Total RNA and protein lysate were isolated from the retina for quantitative (q)RT-PCR and Western blot analyses. RESULTS: Lenti-miR-146a robustly transduced human retinal endothelial cells (HRECs) and increased the expression of miR-146a in vitro. In vivo, intravitreal injection of lenti-miR-146a increased the expression of miR-146a in the retina, while its key downstream target genes, including CARD10, IRAK1, and TRAF6, were downregulated. Intravitreal delivery of miR-146 inhibited diabetes-induced upregulation of NF-κB downstream gene, Intercellular Adhesion Molecule 1 (ICAM1), as well as microvascular leakage and retinal functional defects. CONCLUSIONS: Intravitreal delivery of miR-146 inhibited diabetes-induced NF-κB activation and retinal microvascular and neuronal functional defects in a diabetic rat model.
引用
- Zhuang P, Muraleedharan CK, Xu S, et al. Intraocular Delivery of miR-146 Inhibits Diabetes-Induced Retinal Functional Defects in Diabetic Rat Model. Invest Ophthalmol Vis Sci. 2017. PMID: 28297724. doi:10.1167/iovs.16-21223
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。